Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Respiratory Research
Published in: Respiratory Research 6/2001

Open Access 01-12-2001 | Commentary

Obstructive sleep apnea and vascular disease

Authors: Paola Lanfranchi, Virend A Somers

Published in: Respiratory Research | Issue 6/2001

Login to get access

Abstract

There is emerging evidence linking obstructive sleep apnea (OSA) to vascular disease, including hypertension. This relationship may be independent of co-morbidity, such as obesity. Even apparently healthy OSA patients have evidence of subtle functional vascular abnormalities that are known to occur in patients with hypertension and atherosclerosis. Untreated OSA may possibly contribute to the initiation and/or progression of pathophysiologic mechanisms involved in hypertension, heart failure, cardiac ischemia and stroke. This brief commentary will examine the evidence and mechanisms linking OSA to vascular disease.
Literature
1.
He J, Kryger MH, Zorick FL, Conway W, Roth T: Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest. 1988, 94: 9-14.PubMedCrossRef
2.
Narkiewicz K, Psek CA, Kato M, Phillips BG, Davison DE, Somers VK: Baroreflex control of sympathetic activity and heart rate in obstructive sleep apnea. Hypertension. 1998, 32: 1039-1043.PubMedCrossRef
3.
Narkiewicz K, van de Borne PJ, Peseck CA, Dyken ME, Montano N, Somers VK: Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation. 1999, 99: 1183-1189.PubMedCrossRef
4.
Young T, Palta M, Dempsey J, Skarrud J, Weber S, Badr S: The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993, 328: 1230-1235. 10.1056/NEJM199304293281704.PubMedCrossRef
5.
Brooks D, Horner RL, Kozar LF, Render-Texeira CL, Phillipson EA: Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest. 1997, 99: 106-109.PubMedPubMedCentralCrossRef
6.
Davies CWH, Crosby JH, Mullins RL, Barbour C, Davies JO, Stradling JR: Case control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apneoa and normal matched control subjects. Thorax. 2000, 55: 736-740. 10.1136/thorax.55.9.736.PubMedPubMedCentralCrossRef
7.
Nieto FJ, Young TB, Bonnie KL, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz M, Pickering TC, for the Sleep Heart Health Study: Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA. 2000, 283: 1829-1836. 10.1001/jama.283.14.1829.PubMedCrossRef
8.
Bixler EO, Vgontzas AN, Lin HN, Ten Have T, Leiby BE, Vela-Bueno A, Kales A: Association of hypertension and sleep-disordered breathing. Arch Intern Med. 2000, 160: 2289-2295. 10.1001/archinte.160.15.2289.PubMedCrossRef
9.
Peppard PE, Young T, Palta M, Skatrud J: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000, 342: 1378-1784. 10.1056/NEJM200005113421901.PubMedCrossRef
10.
Mayer J, Becher H, Brandenburg U, Penzel T, Peter JH, von Wichert P: Blood pressure and sleep apnea: results of long-term nasal continuous positive airway pressure therapy. Cardiology. 1991, 79: 84-92.PubMedCrossRef
11.
Wilcox I, Grunstein RR, Hedner JA, Doyle J, Collins FL, Fletcher PJ, Kelly DT, Sullivan CE: Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea. Sleep. 1993, 16: 539-544.PubMed
12.
Suzuki M, Otsuka K, Guilleminault C: Long-term nasal continuous positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients. Sleep. 1993, 16: 545-549.PubMed
13.
Palomaki H, Partinen M, Juvela S, Kaste M: Snoring as a risk factor for sleep-related brain infarction. Stroke. 1989, 10: 1311-1315.CrossRef
14.
15.
Dyken ME, Somers VK, Yamada T, Ren Z, Zimmerman MB: Investigating the relationship between stroke and obstructive sleep apnea. Stroke. 1996, 27: 401-407.PubMedCrossRef
16.
17.
Narkiewicz K, Kato M, Phillips BG, Pesek CA, Davison DE, Somers VK: Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation. 1999, 100: 2332-2335.PubMedCrossRef
18.
Stradling JR, Barbour C, Glennon J, Langford BA, Crosby JH: Which aspects of breathing during sleep influence the overnight fall of blood pressure in a community population?. Thorax. 2000, 55: 393-398. 10.1136/thorax.55.5.393.PubMedPubMedCentralCrossRef
19.
20.
Kourembanas S, Marsden PA, McQuillan LP, Faller DV: Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest. 1991, 88: 1054-1057.PubMedPubMedCentralCrossRef
21.
Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, Somers VK: Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens. 1999, 17: 61-66. 10.1097/00004872-199917010-00010.PubMedCrossRef
22.
Panza JA, Quyyumi AA, Brush JE: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990, 323: 22-27.PubMedCrossRef
23.
Celermajer DS, Sorensen KE, Gooch VM: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992, 340: 1111-1115. 10.1016/0140-6736(92)93147-F.PubMedCrossRef
24.
Kato M, Roberts-Thomson P, Phillips BG, Haynes WG, Winnicki M, Accurso V, Somers VK: Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation. 2000, 102: 2607-2610.PubMedCrossRef
25.
Narkiewicz K, Montano N, Cogliati C, van de Borne PJH, Dyken ME, Somers VK: Altered cardiovascular variability in obstructive sleep apnea. Circulation. 1998, 98: 1071-1077.PubMedCrossRef
26.
Saul JP, Arai Y, Berger RD, Lilly LS, Colucci WS, Cohen RJ: Assessment of autonomic regulation in chronic congestive heart failure by spectral analysis. Am J Cardiol. 1988, 61: 1292-1299.PubMedCrossRef
27.
Kleiger RE, Miller JP, Bigger JT, Moss AJ: Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987, 59: 256-262.PubMedCrossRef
28.
Fauchier L, Babuty D, Cosnay P, Autret ML, Fauchier JP: Heart rate variability in idiopathic dilated cardiomyopathy: characteristics and prognostic value. J Am Coll Cardiol. 1997, 30: 1009-1014. 10.1016/S0735-1097(97)00265-9.PubMedCrossRef
29.
Frattola A, Parati G, Cuspidi C, Albini F, Mancia G: Prognostic value of 24-hour blood pressure variability. J Hypertens. 1993, 11: 1133-1137.PubMedCrossRef
30.
Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Porcellati C: Nocturnal pressure is the true blood pressure. Blood Press Monit. 1996, 1(suppl 2): S81-S85.
31.
Faccenda JF, Mackay TW, Boon NA, Douglas NJ: Randomized placebo-controlled trial of continous positive airway pressure on blood pressure in the sleep apnea–hypopnea syndrome. Am J Respir Crit Care Med. 2001, 163: 344-348.PubMedCrossRef
Metadata
Title
Obstructive sleep apnea and vascular disease
Authors
Paola Lanfranchi
Virend A Somers
Publication date
01-12-2001
Publisher
BioMed Central
Published in
Respiratory Research / Issue 6/2001
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/rr79

Other articles of this Issue 6/2001

Respiratory Research 6/2001 Go to the issue

Review

Small airway inflammation in asthma

Review

Implications of post-pneumonectomy compensatory lung growth in pulmonary physiology and disease

Review

'CFTR-opathies': disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations

Commentary

Childhood infections and asthma: at the crossroads of the hygiene and Barker hypotheses

Review

The role of collagenase in emphysema

Review

Surfactant alteration and replacement in acute respiratory distress syndrome
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits